Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rank in Stocks #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Share Price
$1.51
Last synced: 2024-08-26
Market Cap
$1.12M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Agile Therapeutics, Inc. (AGRX)

Category

EPS for Agile Therapeutics, Inc. (AGRX)
EPS as of June 2024 TTM: $-3.23
According to Agile Therapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is $-3.23. At the end of 2022 the company had a EPS of $-58.79 a decrease compared to its 2021 EPS that were of $-63.12K.
EPS history for Agile Therapeutics, Inc. from 2012 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-3.23 -51.86%
2023 $-6.71 -88.59%
2022 $-58.79 -99.91%
2021 $-63.12K 4,786.76%
2020 $-1.29K 73.08%
2019 $-746.20 -35.27%
2018 $-1.15K -36.99%
2017 $-1.83K -10.01%
2016 $-2.03K -26.22%
2015 $-2.76K -2.35%
2014 $-2.82K -11.05%
2013 $-3.17K -38.43%
2012 $-5.15K 0.00%
EPS for similar companies or competitors